SCHEDULE: Deep Track Capital Boosts Geron Stake to 6.75%
Beneficial Ownership Disclosure
Deep Track Capital and affiliates disclosed a 6.75% beneficial ownership stake in Geron Corp, holding 43 million shares as of June 30, 2025.
Summary
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 43,000,000 shares of Geron Corp's Common Stock.
- This ownership represents 6.75% of Geron Corp's outstanding common stock.
- The calculation of the percentage is based on 636,917,758 shares outstanding as of May 2, 2025, as reported in Geron Corp's 10-Q filing on May 7, 2025.
- All 43,000,000 shares are held with shared voting and shared dispositive power among the reporting persons.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing.
- The reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing control of Geron Corp.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual disclosure of ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It simply reports a significant stake by an institutional investor.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding Geron Corp's future performance or strategic direction.
Industry Context
This filing indicates a significant institutional investment in Geron Corp, a biotechnology company. Such disclosures are common in the biotech sector, where specialized funds often take substantial positions in companies developing novel therapies. The investment by Deep Track Capital, a firm focused on biotechnology, suggests a belief in Geron's long-term potential, likely tied to its drug development pipeline.
Related Party Transactions
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin are filing jointly as a group, with David Kroin identified as a control person for Deep Track Capital, LP.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Deep Track Capital may be viewed positively by other shareholders, signaling confidence from a specialized investment firm in Geron Corp's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of Geron Corp's outstanding common stock count (636,917,758 shares) used for percentage calculation. |
| 05/07/2025 | Date Geron Corp filed its 10-Q with the SEC, providing the outstanding share count. |
| 06/30/2025 | Date of event which required the filing of this statement (measurement date for beneficial ownership). |
| 08/14/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Geron Corp, Deep Track Capital, Deep Track Biotechnology Master Fund, David Kroin, Beneficial Ownership, Common Stock, Biotechnology, Investment, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.